2-23-10 Small Cap Market News and Stock Highlights from SmallCapVoice.com
Stocks are lower after worse-than-expected consumer confidence report
A sharp drop in consumer confidence is sending stocks lower.
The Conference Board says Tuesday its consumer confidence index has fallen to 46 in February from 56.5 last month. Economists had expected a reading of 55.
Not only did the index fall sharply, it is far from indicating strength in the economy. A reading above 90 means the economy is on solid footing.
Consumers are vital to a strong, sustained economic recovery because their spending accounts for more than two-thirds of all economic activity.
The Dow Jones industrial average is down 36.43, or 0.4 percent, at 10,346.95. The Standard & Poor’s 500 index is down 6.32, or 0.6 percent, at 1,101.69, while the Nasdaq composite index is down 14.52, or 0.7 percent, at 2,227.51.
Yesterday’s Top Performing Small Cap Stock:
Tootie Pie Company, Inc. (OTCMKTS: TOOT) was a SmallCapVoice.com top performer yesterday closing up over 6% on trading volume of 25,314 shares.
Tootie Pie reported the best overall quarterly operating results in the Company’s history. The shift to increase retail sales growth from existing and planned acquisitions has positioned Tootie Pie for continued sales growth and profits.
A new Audio Interview with Don Merrill, President and CEO of Tootie Pie Company is now at SmallCapVoice.com. The interview can be heard at https://smallcapvoice.com/blog/2-17-10-audio-interview-with-tootie-pie-company-otcbb-toot/
A fact sheet on Tootie Pie Company, Inc. is available here: https://www.smallcapvoice.com/toot/factsheet.html
Today’s SmallCapVoice.com Hot Stock to Watch:
CitySide Tickets, Inc. (Pink Sheets: CIST)
CitySide Tickets, Inc. Signs Letter of Intent for 100% Ownership in Ticket Broker StadiumTickets.com
Company to Enter Agreement for Ownership of InternationalEntertainment Broker
Feb. 22, 2010 (Business Wire) — CitySide Tickets, Inc. (Pink: CIST), which owns and operates www.CitySidetickets.com, a nationwide event ticket purchasing venue that caters to a diverse selection of popular theater, music, and sporting events, today announces that it has signed a Letter of Intent with StadiumTickets.com, an international entertainment and event ticket broker exchange. Terms of the letter include a 100% ownership in StadiumTickets.com by CitySide Tickets, Inc. The website, www.stadiumtickets.com, will be live and accepting broker orders on March 1st.
SmallCapVoice Clients’ News
Tie Technologies, Inc. (Pink: TTCS)
Graham Mew, Executive Vice President, TIE Technologies, Inc., Updates Shareholders on Recent News in Audio Interview at SmallCapVoice.com
Feb. 23, 2010 (Business Wire) — SmallCapVoice.com, Inc. announced today that a new audio interview profiling TIE Technologies, Inc. (Pink: TTCS) is now available. The interview can be heard at http://smallcapvoice.com/blog/2-22-10-audio-interview-with-tie -technologies-inc-pink-sheets-ttcs/.
Other Small Cap News
AMICAS, Inc. (Nasdaq: AMCS)
AMICAS Files Amended Proxy Materials; Confirms Receipt of Highly-Conditional Acquisition Proposal From Merge Healthcare
The AMICAS Board and management team have actively engaged with Merge and its advisors in an attempt to negotiate a transaction that is in the best interest of AMICAS’ stockholders. After carefully reviewing Merge’s most recent proposal, the AMICAS Board, consulting with its independent financial and legal advisors, determined that the Merge proposal is not a Superior Proposal as defined under the Thoma Bravo Merger. Merge has failed to provide sufficient financial guarantees and reasonable protections for AMICAS stockholders.
ICOP Digital, Inc. (Nasdaq: ICOP)
ICOP Digital, Inc. and L-3 Communications Mobile-Vision, Inc. Resolve Patent Litigation
ICOP Digital, Inc. (NASDAQ: ICOP), today announced that it has resolved all currently pending litigation with L-3 Communications Mobile-Vision, Inc. (“L-3″). ICOP maintains, and continues to maintain, that it does not infringe United States Patent No. 7,119,832. All litigation between the parties has been dismissed with prejudice and the ICOP 20/20, 20/20-W, 20/20 VISION, the wireless microphone and base remain available for purchase from ICOP. The terms of the resolution are confidential.
CEL-SCI Corporation (NYSE Amex: CVM)
CEL-SCI Study Shows CEL-2000 Vaccine Blocks Progression of Rheumatoid Arthritis
Statistically Significant Findings Published in Prestigious Journal of International Immunopharmacology
Geert Kersten, Chief Executive Officer of CEL-SCI said, “These experimental results were achieved through a reduction of the inflammatory response that is known to attack the patients’ joints. The mode of action of CEL-2000 in RA appears to be similar to our new investigational therapy for H1N1 hospitalized patients, as it attempts to avoid the excess TNF-alpha and other pro-inflammatory cytokines. We feel that this new data is encouraging both for this rheumatoid arthritis vaccine as well as in support of our H1N1 treatment currently under development.”
OPKO Health, Inc. (NYSE Amex: OPK)
OPKO Health Announces Collaboration with Mexican Research Center
OPKO Health, Inc. (NYSE Amex: OPK) today announced the signing of a letter of intent to collaborate with the Centro de Investigación y Asistencia Tecnológica y Diseño del Estado de Jalisco (CIATEJ), a preeminent technology and research center in the State of Jalisco, Mexico. The organizations intend to initially develop and manufacture vaccines for flu, dengue fever, and West Nile virus.
NIVS IntelliMedia Technology Group, Inc. (NYSE Amex: NIV)
NIVS Announces Preliminary Results of Operations for 2009
“We are encouraged to report strong estimated revenue and net income growth for fiscal 2009. The improvement in our working capital position at year-end as compared to the previous year-end period is also encouraging,” commented Mr. Tianfu Li, NIVS’ Chairman and Chief Executive Officer.
BSD Medical Corporation (Nasdaq: BSDM)
BSD Medical Reports Publication of Chinese Study Using the BSD-2000 Hyperthermia System to Treat Lung Cancer
The clinical study, conducted at a prestigious hospital in China, involved 60 patients with non-small cell lung cancer (NSCLC) who were randomized to receive either chemotherapy (cisplatin and paclitaxel) combined with hyperthermia (delivered using the BSD-2000 Hyperthermia System) or chemotherapy without hyperthermia.
Satcon Technology Corporation (Nasdaq: SATC)
Satcon Receives Largest Single Order to Date, Extending Its Global Leadership Position in Utility Scale Solar
“The utility scale solar power market in the Czech Republic is poised for significant growth in 2010 as demonstrated by these projects,” said Daniel Kunz, Chief Executive Officer of ENERGY 21. “Satcon is a trusted partner of ENERGY 21. Our experience working with them on some of the largest installations across the Czech Republic and Slovakia over the past two years gives us tremendous confidence that these new solar plants will deliver the highest level of reliability and performance, and provide the strongest value to our shareholders.”
Immunomedics, Inc. (Nasdaq: IMMU)
Immunomedics Awarded Patents for Antibody for PEGylation and Pretargeting Constructs
“This extends our existing family of DNL patents to allow production of PEGylated forms of virtually any therapeutic agent. Products currently under development include PEGylated interferon alpha, granulocyte colony-stimulating factor and erythropoietin with superior pharmacokinetic properties,” commented Cynthia L. Sullivan, President and CEO.
About SmallCapVoice.com
SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide. Known for its ability to help emerging growth companies build a following among retail and institutional investors, SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its client’s financial news releases. SmallCapVoice.com also offers individual investors with all the tools they need to make informed decisions about the stocks they are interested in. Tools like our stock charts, stock alerts, and our investor fact sheets can assist with investing in stocks that are traded on the OTC Markets.
Small-Cap Voice SCV is an electronic publication, and is for informational purposes only. The stocks profiled by SCV are only company profiles and are not intended to be and should not be accepted by you as recommendations to buy or sell in these securities. These profiles are compiled from publicly available sources. Our sources include, but are not limited to, online research, company profiles, member suggestions, magazines, newspapers, analyst suggestions, broker recommendations, contact with the company, company rumors, press releases and other similar information sources. All profiles are based on information that is accessible by the public. Investing in stocks involves risk. SCV is not and does not hold itself out to be a registered broker or dealer or other licensed securities professional. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. For compensation and a complete disclaimer click here.
Contact:
Stuart T. Smith CEO
512-267-2430
ssmith@smallcapvoice.com
https://www.smallcapvoice.com
The preceding article is from one of our external contributors. It does not represent the opinion of Benzinga and has not been edited.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
